Physiomics Plc
PYC.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.02 | -0.00 | -0.01 | 0.07 |
| FCF Yield | -20.64% | -1,897.50% | -13.07% | -16.33% |
| EV / EBITDA | -4.09 | 1.04 | -3.34 | -7.58 |
| Quality | ||||
| ROIC | -37.70% | -60.81% | -141.20% | -30.79% |
| Gross Margin | -38.75% | -83.28% | -219.62% | -61.78% |
| Cash Conversion Ratio | 1.42 | 1.23 | 0.49 | 1.71 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.37% | -9.37% | -9.31% | -0.85% |
| Free Cash Flow Growth | 6.99% | -34.15% | 39.82% | -333.14% |
| Safety | ||||
| Net Debt / EBITDA | 2.29 | 1.10 | 0.45 | 1.74 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | -12.45 | 0.00 |
| Cash Conversion Cycle | 56.14 | 53.64 | 59.61 | 74.24 |